Treating early versus treating mild: Timing of migraine prescription medications among patients with diagnosed migraine

Headache

Volumn 45, Issue 5, 2005, Pages 538-545

  Foley, Kathleen A ^a   Cady, Roger ^b   Martin, Vincent ^c   Adelman, James ^d   Diamond, Merle ^e   Bell, Christopher F ^a   Dayno, Jeffrey M ^a   Hu, X Henry ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b HEADACHE CARE CENTER   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^d Headache Wellness Center   (United States)

^e DIAMOND HEADACHE CLINIC   (United States)

Author keywords

Decision making; Early treatment; Migraine; Migraine medication; Patient; Treatment delay

Indexed keywords

ANALGESIC AGENT; ERGOT DERIVATIVE; ISOMETHEPTENE MUCATE; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; RIZATRIPTAN; SEDATIVE AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; MIGRAINE WITH AURA; MIGRAINE WITHOUT AURA; PATIENT COMPLIANCE; PRESCRIPTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SELF EVALUATION;

ADOLESCENT; ADULT; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MIGRAINE WITH AURA; PATIENT COMPLIANCE; PROSPECTIVE STUDIES; QUESTIONNAIRES; TIME FACTORS;

EID: 20544464115     PISSN: 00178748     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2005.05107.x     Document Type: Article

References (14)

1. Cady RK, Lipton RB, Hall C, Stewart WF, O'Quinn S, Gutterman D. Treatment of mild headache in disabled migraine sufferers: results of the spectrum study. Headache. 2000;40:792-797.
2. Cady RK, Sheftell F, Lipton RB, et al. Effect of early intervention with sumatriptan on migraine pain: retrospective analyses of data from three clinical trials. Clin Ther. 2000;22:1035-1048.
3. Pascual J, Cabarrocas X. Within-patient early versus delayed treatment of migraine attacks with almotriptan: the sooner the better. Headache. 2002;42:28-31.
4. Matthews N, Kailasam J, Meadors L. Early treatment of migraine with rizatriptan: a placebo-controlled study. Headache. 2004;44:669-673.
5. Burstein R. Collins B, Jakubowski M. Defeating migraine pain with triptans: a race against the development of cutaneous allodynia. Ann Neurol. 2004;55:19-26.
6. Ferrari A, Stefani M, Sternieri A, Bertolotti M, Sternieri E. Analgesic drug taking: beliefs and behavior among headache patients. Headache. 1997;37:88-94.
7. Hu X, Raskin NH, Cowan R, Markson LE, Berger ML. Treatment of migraine with rizatriptan: when to take the medication. Headache. 2002;42:16-20.
8. Ivers H, McGrath PJ, Purdy A, Hennigar AW, Campbell M. Decision making in migraine patients taking sumatriptan: an exploratory study. Headache. 2000;40:129-136.
9. Gallagher RM, Kunkel R. Migraine medication attributes important for patient compliance: concerns about side effects may delay treatment. Headache. 2003;43:36-43.
10. Cady R, Martin V, Adelman J, Diamond M, Sajjan S, Hu X. Migraine treatment with rizatriptan and non-triptan usual care medications: a pharmacy-based study. Headache. 2004;44:900-907.
11. Freitag FG, Cady R, DiSerio F, et al. Comparative study of a combination of isometheptene mucate, dicholoralphenazone with acetaminophen and sumatriptan succinate in the treatment of migraine. Headache. 2001;41:391-398.
12. Stang PE, VonKorff M. The diagnosis of headache in primary care: factors in the agreement of clinical and standardized diagnoses. Headache. 1995;34:138-142.
13. Giffin NJ, Ruggiero L, Lipton RB, et al. Premonitory symptoms in migraine: an electronic diary study. Neurology. 2003;60:935-940.
14. Cady R, Schreiber, Farmer K, Sheftell F. Primary headaches: a convergence hypothesis. Headache. 2002;42:204-216.